| Dr Raina M Lourens, MD | |
|
35 Medical Center Parkway, Augusta, ME 04330-8160 | |
| (207) 622-1959 | |
| (207) 430-4007 |
| Full Name | Dr Raina M Lourens |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 35 Medical Center Parkway, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760640056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD19162 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kennebec Anesthesia Associates Pa | 8325027428 | 35 |
News Archive
A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.
Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.
Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and others has found that standard heart disease risk assessment tools may underrate the danger a particular person faces.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
New research from McGill University reveals an overlooked impact that the widely used herbicide glyphosate may be having on the environment.
› Verified 2 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.
Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.
Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and others has found that standard heart disease risk assessment tools may underrate the danger a particular person faces.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
New research from McGill University reveals an overlooked impact that the widely used herbicide glyphosate may be having on the environment.
› Verified 2 days ago
| Entity Name | Kennebec Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992789184 PECOS PAC ID: 8325027428 Enrollment ID: O20040714000140 |
News Archive
A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.
Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.
Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and others has found that standard heart disease risk assessment tools may underrate the danger a particular person faces.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
New research from McGill University reveals an overlooked impact that the widely used herbicide glyphosate may be having on the environment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raina M Lourens, MD 35 Medical Center Parkway, Augusta, ME 04330-8160 Ph: (207) 622-1959 | Dr Raina M Lourens, MD 35 Medical Center Parkway, Augusta, ME 04330-8160 Ph: (207) 622-1959 |
News Archive
A study by researchers at UC Davis has found that pregnant women with a particular gene variation are more likely to produce autoantibodies to the brains of their developing fetuses and that the children of these mothers are at greater risk of later being diagnosed with autism.
Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.
Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and others has found that standard heart disease risk assessment tools may underrate the danger a particular person faces.
A new Tel Aviv University study finds that eosinophils - white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies - may be used to eliminate malignant colon cancer cells.
New research from McGill University reveals an overlooked impact that the widely used herbicide glyphosate may be having on the environment.
› Verified 2 days ago
Brian P Mills, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Jason Wyse, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Dr. Joel D Smith, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-622-1959 | |
Noah Thomas Sutton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy Ste 201, Augusta, ME 04330 Phone: 207-620-1136 | |
James P Decourcey, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Dr. Francis J Griffin, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 |